Biography
Pieter van Baal is a Professor of Public Health Economics. His research focuses on the methodology of cost effectiveness analyses, modeling of diseases/population health and the relation thereof with (non)medical consumption. He has extensive experience in economic evaluations of public health interventions, Markov modeling, uncertainty analyses and is the main developer of PAID (Practical Application to Include future Disease costs).
Pieter has served on the editorial boards of PLoS One, Population Health Metrics and currently is an associate editor of Value of Health.
Erasmus School of Health Policy & Management
Full professor | Health Economics (HE)
- vanbaal@eshpm.eur.nl
More information
Work
- Elena Milkovska, Bram Wouterse, Jawa Issa & Pieter Van Baal (2025) - Quantifying the health burden of COVID-19 using individual estimates of years of life lost based on population-wide administrative level data - Epidemiology, 36 (4), 520-530 - doi: 10.1097/ede.0000000000001854 - [link]
- Nancy J. Devlin, C. Daniel Mullins & Pieter van Baal (2025) - What Does ‘Whole Health’ Really Mean for Health Economics and Outcomes Research? - Value in Health, 28 (5), 699-701 - doi: 10.1016/j.jval.2025.03.006 - [link]
- Saskia de Groot, Hedwig M. Blommestein, Brenda Leeneman, Carin A. Uyl-de Groot, John B.A.G. Haanen, Michel W.J.M. Wouters, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Willeke A.M. Blokx, Marye J. Boers-Sonderen, Alfons J.M. van den Eertwegh, Jan Willem B. de Groot, Geke A.P. Hospers, Ellen Kapiteijn, Olivier J. van Not, Astrid A.M. van der Veldt, Karijn P.M. Suijkerbuijk & Pieter H.M. van Baal (2025) - Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced Melanoma - Medical Decision Making, 45 (3), 302-317 - doi: 10.1177/0272989X251319338 - [link]
- Linda M. de Vries, Werner B.F. Brouwer & Pieter H.M. van Baal (2024) - Benefits beyond health in the willingness to pay for a quality-adjusted life-year - European Journal of Health Economics, 26 (4), 653-670 - doi: 10.1007/s10198-024-01726-7 - [link]
- Ting Zhao, Michelle Tew, Talitha Feenstra, Pieter van Baal, Michael Willis, William J. Valentine, Philip M. Clarke, Barnaby Hunt, James Altunkaya, An Tran-Duy, Richard F. Pollock, Samuel J.P. Malkin, Andreas Nilsson, Phil McEwan, Volker Foos, Jose Leal, Elbert S. Huang, Neda Laiteerapong, Mark Lamotte, Harry Smolen, Jianchao Quan, Luís Martins, Mafalda Ramos & Andrew J. Palmer (2024) - The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes - Applied Health Economics and Health Policy, 22 (6), 861-869 - doi: 10.1007/s40258-024-00914-z - [link]
- Jawa Issa, Tom Van Ourti, Pieter van Baal & Owen O'Donnell (2024) - Ranking Age-at-Death Distributions Using Dominance: Robust Evaluation of United States Mortality Trends, 2006-2021 - Demography, 61 (4), 1143-1159 - doi: 10.1215/00703370-11460856 - [link]
- Nilmini Wijemunige, Pieter van Baal, Ravindra P Rannan-Eliya & Owen O'Donnell (2024) - Health outcomes and healthcare utilization associated with four undiagnosed chronic conditions: evidence from nationally representative survey data in Sri Lanka - BMC Global and Public Health, 2 (1) - doi: 10.1186/s44263-024-00075-0
- Hamraz Mokri, Pieter van Baal & Maureen Rutten-van Mölken (2024) - The impact of different perspectives on the cost-effectiveness of remote patient monitoring for patients with heart failure in different European countries - European Journal of Health Economics, 26 (1), 71-85 - doi: 10.1007/s10198-024-01690-2 - [link]
- Hamraz Mokri, Pascal R.D. Clephas, Rudolf A. de Boer, Pieter van Baal, Jasper J. Brugts & Maureen P.M.H. Rutten-van Mölken (2024) - Cost-effectiveness of remote haemodynamic monitoring by an implantable pulmonary artery pressure monitoring sensor (CardioMEMS-HF system) in chronic heart failure in the Netherlands - European Journal of Heart Failure, 26 (5), 1189-1198 - doi: 10.1002/ejhf.3213 - [link]
- Pieter van Baal & Pedro Pita Barros (2024) - Drug Pricing, Patient Welfare, and Cost-Effectiveness Analysis - Value in Health, 27 (3), 271-272 - doi: 10.1016/j.jval.2024.01.006 - [link]
Zorginstituut Nederland
- Start date approval
- november 2023
- End date approval
- augustus 2026
- Place
- DIEMEN
- Description
- Lid Adviescommissie Pakket (ACP) Zorginstituut
Master Thesis HEPL
- Level
- master
- Year Level
- master
- Year
- 2024
- Course Code
- GW4555M
Rationing Health Care
- Level
- Bachelor 3
- Year Level
- Bachelor 3
- Year
- 2024
- Course Code
- GW301
Master Thesis HE
- Year Level
- master, master
- Year
- 2024
- Course Code
- GW4592M
